Conclusion: This study not only proposed a high-precision clinical prediction model composed of various variables for the early diagnosis of Xp11.2 translocation/TFE3 gene fusion renal cell carcinoma but also optimized therapeutic strategies through prognostic analysis. This evidence concerns the gene TFE3 and hereditary clear cell renal cell carcinoma.